Free to total Prostate-Specific Antigen (PSA) ratio improves the discrimination between prostate cancer and benign prostatic hyperplasia (BPH) in the diagnostic gray zone of 1.8 to 10 ng/mL total PSA-Reference-Cited by-同舟云学术

Free to total Prostate-Specific Antigen (PSA) ratio improves the discrimination between prostate cancer and benign prostatic hyperplasia (BPH) in the diagnostic gray zone of 1.8 to 10 ng/mL total PSA

Published:1996-12 Issue:6 Volume:48 Page:67-70
ISSN:0090-4295
Container-title:Urology
language:en
Short-container-title:Urology

Author:

Van Cangh Paul J.,De Nayer Philippe,De Vischer Luc,Sauvage Philippe,Tombal Bertrand,Lorge Francis,Wese François X.,Opsomer Reinier

Publisher

Elsevier BV

Subject

Urology

Reference7 articles.

1. A complex between prostatespecific antigen and α1-antichymotrypsin is the major form of prostate-specific antigen in serum of patients with prostatic cancer: assay of the complex improves clinical sensitivity for cancer;Stenmann;Cancer Res,1991

2. Evaluation of free serum prostate-specific antigen to improve specificity of prostate cancer screening;Catalona;JAMA,1995

3. Using proportions of free to total prostatespecific antigen, age, and total prostate-specific antigen to predict the probability of prostate cancer;Chen;Urology,1996

4. Measurement of the proportion of free to total prostate-specific antigen improves diagnostic performance of prostate-specific antigen in the diagnostic gray zone of total prostate-specific antigen;Luderer;Urology,1995

5. Free, complexed and total serum prostate specific antigen: the establishment of appropriate reference ranges for their concentrations and ratios;Oesterling;J Urol,1995

Cited by 43 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prostate-specific antigen reduction after empiric antibiotic treatment does not rule out biopsy in patients with lower urinary tract symptoms: prospective, controlled, single-center study;Prostate International;2017-06

2. Urinary Polyamines: A Pilot Study on Their Roles as Prostate Cancer Detection Biomarkers;PLOS ONE;2016-09-06

3. The cutoff level of free/total prostate specific antigen (f/t PSA) ratios in the diagnosis of prostate cancer: A validation study on a Turkish patient population in different age categories;The Kaohsiung Journal of Medical Sciences;2014-11

4. The Impact of Free/Total PSA Ratio on Prostate Cancer Diagnosis in Patients with PSA Level Between 2,5-10 mg/dl Undergoing Transrectal Prostate Biopsy;Annals of Clinical and Analytical Medicine;2014

5. On-chip screening for prostate cancer: an EIS microfluidic platform for contemporary detection of free and total PSA;The Analyst;2013